US MDA contracts Applied DNA Sciences to develop anti-counterfeiting platform
The US Missile Defense Agency (MDA) has awarded a phase I research grant to Applied DNA Sciences (ADPN) to advance development of its DNA-based anti-counterfeiting platform for military electronics.
Awarded as part of the agency's small business innovative research (SBIR) programme, the $150,000 funding seeks production of advanced and innovative methods for placement of markings or coatings onto original parts at the time of component development.
The move will allow customers to confirm the authenticity of components at later stages in the supply chain.
Known as feasibility grant, the phase I award is scheduled to be followed by a competition for phase II and phase II awards, which will involve implementation and commercialisation respectively.
The latest funding is separate from the research and testing supported by the US Defense Logistics Agency (DLA), which prepared the platform for inclusion into all items in a class of electronics provided by contractors to the agency.
Commenting on the contract, Applied DNA Sciences president and CEO Dr James Hayward said the SBIR research award reflected the widespread interest that has been generated by the company's technology in the military and its suppliers.
"The research for MDA will aid our ongoing work in expanding the range of applications of SigNature DNA, further compressing the time used to mark and authenticate items, and opening up the ability to use still more and varied carriers for our mark," Hayward said.
"We are optimistic that we will be able to take this research project through implementation and move to the commercialisation stage."
SigNature DNA is a highly secure, robust and cost-efficient marker designed to fortify brand protection efforts, in addition to marking, tracking and convicting criminals and securing supply chains.